{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:50:43Z","timestamp":1768809043340,"version":"3.49.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["bestpracticeobgyn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.bpobgyn.2014.04.008","type":"journal-article","created":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T04:16:57Z","timestamp":1399004217000},"page":"769-791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Which imaging technique should we use in the follow up of gynaecological cancer?"],"prefix":"10.1016","volume":"28","author":[{"given":"Antonia Carla","family":"Testa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Di Legge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna","family":"Virgilio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Bonatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paoletta","family":"Mirk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittoria","family":"Rufini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2014.04.008_bib1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00259-008-0956-1","article-title":"Performance of integrated FDG-PET\/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT","volume":"36","author":"Kitajima","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1 Suppl 1","key":"10.1016\/j.bpobgyn.2014.04.008_bib2","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1016\/j.ygyno.2007.07.025","article-title":"Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients","volume":"107","author":"Sartori","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib3","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1471-0528.1997.tb10979.x","article-title":"Recurrence of endometrial carcinoma and the value of routine follow up","volume":"104","author":"Salvesen","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/gyno.1995.1262","article-title":"Postsurgical surveillance of patients with FIGO stage I\/II endometrial adenocarcinoma","volume":"59","author":"Berchuck","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib5","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1148\/rg.234035001","article-title":"Uterine cervical carcinoma after therapy: CT and MR imaging findings","volume":"23","author":"Jeong","year":"2003","journal-title":"Radiographics"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1148\/rg.233025105","article-title":"Multidetector CT of peritoneal carcinomatosis from ovarian cancer","volume":"23","author":"Pannu","year":"2003","journal-title":"Radiographics"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1525-1500.1999.99043.x","article-title":"Role of serial markers in the surveillance for recurrence in endometrial cancer","volume":"23","author":"Lo","year":"1999","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1148\/radiology.196.3.7644634","article-title":"Ovarian cancer recurrence value of MR imaging","volume":"196","author":"Forstner","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib9","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/1097-0142(19890315)63:6<1123::AID-CNCR2820630614>3.0.CO;2-A","article-title":"Comparison of abdominopelvic computed tomography results and findings at second look laparotomy in ovarian carcinoma patients","volume":"63","author":"Reuter","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00001703-200402000-00003","article-title":"New modalities in detection of recurrent ovarian cancer","volume":"16","author":"Tammela","year":"2004","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"57","key":"10.1016\/j.bpobgyn.2014.04.008_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics","volume":"2007","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib12","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2006.03.025","article-title":"Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations","volume":"42","author":"Ferrandina","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3322\/canjclin.51.1.15","article-title":"Cancer statistics, 2001","volume":"51","author":"Greenlee","year":"2001","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11684-014-0305-7","article-title":"Clinical outcomes and prognostic factors of patients with epithelial ovarian cancer subjected to first-line treatment: a retrospective study of 251 cases","volume":"8","author":"Fu","year":"2014","journal-title":"Front Med"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/01.cco.0000174166.06734.c7","article-title":"The role of surgery in ovarian cancer with special emphasis on cytoreductive surgery for recurrence","volume":"17","author":"Harter","year":"2005","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00261-002-0046-y","article-title":"Recurrent ovarian malignancy: patterns and spectrum of imaging findings","volume":"28","author":"Park","year":"2003","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/bmj.39337.615197.80","article-title":"Diagnosis and management of cervical cancer","volume":"335","author":"Petignat","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0360-3016(94)00523-0","article-title":"Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update of a nonrandomized comparison","volume":"31","author":"Perez","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijrobp.2004.02.044","article-title":"Recurrent squamous cell carcinoma of cervix after definitive radiotherapy","volume":"60","author":"Hong","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/annonc\/mdh050","article-title":"Value of routine follow-up procedures for patients with stage I\/II cervical cancer treated with combined surgery-radiation therapy","volume":"15","author":"Morice","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/IGC.0b013e3181e2abcc","article-title":"Surveillance procedures for patients treated for endometrial cancer: a review of the literature","volume":"20","author":"Sartori","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib23","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/sj.bjc.6603787","volume":"96","author":"Pignata","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2006.02.011","article-title":"Follow-up after primary therapy for endometrial cancer: a systematic review","volume":"101","author":"Fung-Kee-Fung","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14694\/EdBook_AM.2012.32.70","article-title":"Surgical options for recurrent uterine sarcomas","volume":"32","author":"Korets","year":"2012","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib26","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bpobgyn.2011.06.002","article-title":"Prognostic factors in uterine sarcoma","volume":"25","author":"Gadducci","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1 Pt 1","key":"10.1016\/j.bpobgyn.2014.04.008_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1148\/radiology.162.1.3538149","article-title":"Recurrent female pelvic cancer: assessment with transrectal ultrasonography","volume":"162","author":"Meanwell","year":"1987","journal-title":"Radiology"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1469-0705.1994.04020135.x","article-title":"Transvaginal sonography in the diagnosis of pelvic malignant recurrence: integration of sonography and needle-guided biopsy","volume":"4","author":"Volpi","year":"1994","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib29","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ygyno.2005.07.116","article-title":"The role of sonographic examination in the follow-up of gynecological neoplasms","volume":"99","author":"Testa","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ygyno.2004.01.024","article-title":"Pelvic relapses of uterine neoplasms: transvaginal sonographic and Doppler features","volume":"93","author":"Savelli","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib31","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1046\/j.1469-0705.2002.00693.x","article-title":"Detection of central pelvic recurrent disease with transvaginal color Doppler ultrasound in women treated for gynecological malignancy","volume":"19","author":"Testa","year":"2002","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/uog.10054","article-title":"Ultrasound scanning of the pelvis and abdomen for staging of gynecological tumors: a review","volume":"38","author":"Fischerova","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/uog.7309","article-title":"Dynamic and interactive gynecological ultrasound examination","volume":"34","author":"Testa","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00004728-200305000-00006","article-title":"Thin section dual-phase multidetector-row computed tomography detection of peritoneal metastases in gynecologic cancers","volume":"27","author":"Pannu","year":"2003","journal-title":"J\u00a0Comput Assist Tomogr"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib35","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejrad.2008.02.019","article-title":"CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis","volume":"71","author":"Gu","year":"2009","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1148\/radiol.10092279","article-title":"Recurrent ovarian cancer: use of contrast-enhanced CT and PET\/CT to accurately localize tumor recurrence and to predict patients' survival","volume":"257","author":"Sala","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2214\/ajr.182.2.1820393","article-title":"Role of CT in the management of recurrent ovarian cancer","volume":"182","author":"Funt","year":"2004","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib38","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1148\/radiology.204.2.9240546","article-title":"Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT","volume":"204","author":"Low","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s13244-010-0042-7","article-title":"Imaging of endometrial and cervical cancer","volume":"1","author":"Patel","year":"2010","journal-title":"Insights Imaging"},{"issue":"1","key":"10.1016\/j.bpobgyn.2014.04.008_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0090-8258(89)90006-1","article-title":"Clinical value of computerized tomography (CT) in assessment of recurrent uterine cancers","volume":"35","author":"Franchi","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2214\/AJR.05.0004","article-title":"Recurrent ovarian cancer: spectrum of imaging findings","volume":"187","author":"Kwek","year":"2006","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib42","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/00004728-199307000-00021","article-title":"CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancer","volume":"17","author":"Prayer","year":"1993","journal-title":"J\u00a0Comput Assist Tomogr"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib43","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1148\/radiology.200.2.8685345","article-title":"Benign and malignant gynecologic disease: clinical importance of fluid and peritoneal enhancement in the pelvis at MR imaging","volume":"200","author":"Outwater","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib44","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/rct.0b013e31803e8c45","article-title":"Detection of recurrent ovarian cancer at MRI: comparison with integrated PET\/CT","volume":"31","author":"Kim","year":"2007","journal-title":"J\u00a0Comput Assist Tomogr"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2214\/ajr.168.2.9016214","article-title":"Invasion of the urinary bladder by uterine cervical carcinoma: evaluation with MR imaging","volume":"168","author":"Kim","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib46","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s11547-008-0312-3","article-title":"Recurrent uterine cancer after surgery: magnetic resonance imaging patterns and their changes after concomitant chemoradiation","volume":"113","author":"Manfredi","year":"2008","journal-title":"Radiol Med"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1148\/radiology.204.1.9205223","article-title":"Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging","volume":"204","author":"Kinkel","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib48","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/jmri.21486","article-title":"Evaluation of locally recurrent pelvic malignancy: performance of T2- and diffusion-weighted MRI with image fusion","volume":"28","author":"Nishie","year":"2008","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib49","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2214\/ajr.175.3.1750759","article-title":"Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma","volume":"175","author":"Yang","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib50","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00261-008-9457-8","article-title":"Imaging of gynecologic malignancies with FDG PET-CT: case examples, physiologic activity, and pitfalls","volume":"34","author":"De Gaetano","year":"2009","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib51","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00261-012-9867-5","article-title":"Spectrum of PET-CT pelvic pitfalls in patients with gynecologic malignancies","volume":"37","author":"Gorospe","year":"2012","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib52","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/cncr.11928","article-title":"Restaging of recurrent cervical carcinoma with dual-phase [18F]Fluoro-2-Deoxy-D-Glucose positron emission tomography","volume":"100","author":"Lai","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib53","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1016\/j.ejrad.2012.03.020","article-title":"Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET\/CT scans for diagnosing ovarian cancer recurrence","volume":"81","author":"Kitajima","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib54","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1007\/s00259-010-1440-2","article-title":"Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET\/CT studies for the diagnosis of uterine cancer recurrence","volume":"37","author":"Kitajima","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib55","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1097\/IGC.0b013e3182a41e61","article-title":"Magnetic resonance imaging\/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration","volume":"23","author":"Vargas","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12149-013-0777-6","article-title":"Value of fusion of PET and MRI in the detection of intra-pelvic recurrence of gynecological tumor: comparison with 18F-FDG contrast-enhanced PET\/CT and pelvic MRI","volume":"28","author":"Kitajima","year":"2014","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1148\/radiol.10092279","article-title":"Recurrent ovarian cancer: use of contrast-enhanced CT and PET\/CT to accurately localize tumor recurrence and to predict patients\u2019 survival","volume":"257","author":"Sala","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib58","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3892\/ol.2012.1075","article-title":"Staging recurrent ovarian cancer with (18)FDG PET\/CT","volume":"5","author":"Dragosavac","year":"2013","journal-title":"Oncol Lett"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib59","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00259-006-0260-x","article-title":"Role of [18F]FDG PET\/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings","volume":"34","author":"Chung","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib60","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1097\/RLU.0b013e31825b2583","article-title":"Revisiting the clinical value of 18F-FDG PET\/CT in detection of recurrent epithelial ovarian carcinomas: correlation with histology, serum CA-125 assay, and conventional radiological modalities","volume":"37","author":"Antunovic","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib61","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/IGC.0b013e3181a3cc94","article-title":"Influence of 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography on recurrent ovarian cancer diagnosis and on selection of patients for secondary cytoreductive surgery","volume":"19","author":"Risum","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib62","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000159266","volume":"75","author":"Fagotti","year":"2008","journal-title":"Oncology"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib63","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MNM.0000000000000051","article-title":"Is there an impact of 18F-FDG PET\/CT on the surveillance and clinical management of recurrent ovarian cancer? Research based on a large sample in a single PET\/CT center","volume":"35","author":"Chen","year":"2014","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib64","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/IGC.0b013e31828a183c","article-title":"Accuracy of positron emission tomography\/computed tomography in the diagnosis and restaging for recurrent ovarian cancer: a meta-analysis","volume":"23","author":"Limei","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib65","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2006.03.004","article-title":"The impact of PET\/CT in the management of recurrent ovarian cancer","volume":"103","author":"Simcock","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib66","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ygyno.2008.08.027","article-title":"The impact of PET-CT in suspected recurrent ovarian cancer: a prospective multi-centre study as part of the Australian PET Data Collection Project","volume":"112","author":"Fulham","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib67","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1007\/s00330-008-0979-9","article-title":"Performance of FDG-PET\/CT for diagnosis of recurrent uterine cervical cancer","volume":"18","author":"Kitajima","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib68","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00259-013-2610-9","article-title":"Impact of FDG PET in optimizing patient selection for cytoreductive surgery in recurrent ovarian cancer","volume":"41","author":"Ebina","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"suppl 1","key":"10.1016\/j.bpobgyn.2014.04.008_bib69","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1525-1438.2006.00471.x","article-title":"Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer","volume":"16","author":"Murakami","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib70","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ygyno.2004.12.007","article-title":"FDG-PET for management of cervical and ovarian cancer","volume":"97","author":"Havrilesky","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib71","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11307-010-0468-9","article-title":"Value of FDG PET\/CT in patients with treated ovarian cancer and raised CA125 serum levels","volume":"14","author":"Palomar","year":"2012","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib72","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF03027393","article-title":"Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer","volume":"19","author":"Khan","year":"2005","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib73","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/IGC.0b013e3181e82a7f","article-title":"Clinical utility of positron emission tomography\/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels","volume":"20","author":"Bhosale","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib74","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/cncr.20349","article-title":"Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study","volume":"101","author":"Chang","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib75","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ygyno.2004.04.021","article-title":"Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women","volume":"94","author":"Unger","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib76","first-page":"347","article-title":"Detection of early recurrence with 18F-FDG PET in patients with cervical cancer","volume":"44","author":"Ryu","year":"2003","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib77","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00259-005-1876-y","article-title":"18F-FDG PET in the management of endometrial cancer","volume":"33","author":"Chao","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib78","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ygyno.2008.01.030","article-title":"Role of PET or PET\/CT in the post-therapy surveillance of uterine sarcoma","volume":"109","author":"Park","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib79","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1258\/ar.2011.100509","article-title":"Fluorine-18-fluorodeoxyglucose PET\/CT for the evaluation of suspected recurrent uterine leiomyosarcomas","volume":"52","author":"Kao","year":"2011","journal-title":"Acta Radiol"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib80","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/RLU.0b013e31824d24fa","article-title":"Carcinoma endometrium: role of 18-FDG PET\/CT for detection of suspected recurrence","volume":"37","author":"Sharma","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib81","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/RLU.0b013e31826390ec","article-title":"Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18F-FDG PET\/CT","volume":"38","author":"Kim","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.bpobgyn.2014.04.008_bib82","first-page":"1775","article-title":"Delayed (18)F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients","volume":"44","author":"Ma","year":"2003","journal-title":"J\u00a0Nucl Med"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693414000650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693414000650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T18:48:16Z","timestamp":1597776496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693414000650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1521693414000650"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.04.008","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Which imaging technique should we use in the follow up of gynaecological cancer?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}